Serological evidence for SARS-CoV-2 in lactating cows published
On Jun. 4, 2022, researchers reported that in areas with large cattle populations and a high prevalence of…
Food allergy associated with lower risk of SARS-CoV-2 infection
On Jun. 1, 2022, the U.S. National Institutes of Health announced that an NIH funded study had found…
Roche developed unique PCR tests to detect the monkeypox virus
On May 25, 2022, Roche and its subsidiary TIB Molbiol announced they had developed three unique LightMixï¾® Modular…
Computer model predicted dominant SARS-CoV-2 variants
On May 24, 2022, scientists at the Broad Institute of MIT and Harvard and the University of Massachusetts…
WHO announced nulti-country monkeypox outbreak in non-endemic countries
On May 21, 2022, the WHO announced that since May 13, 2022, cases of monkeypox had been reported…
NIH announced antiviral drug development awards
On May 18, 2022, the U.S. National Institutes of Health announced it had awarded approximately $577 million to…
Labcorp received EUA for first non-prescription at-home collection kit for combined COVID-19, Fflu and RSV detection
On May 18, 2022, LabCorp announced the receipt of Emergency Use Authorization (EUA) from the U.S. Food and…
InteliSwabï¾® COVID-19 rapid test validated to detect Omicron BA.2, BA.2.12.1, BA.3 and BA.5 subvariants
On May 17, 2022, OraSure Technologies announced that its InteliSwabï¾® COVID-19 rapid tests detect the Omicron BA.2, BA.2.12.1,…
Cepheid received Emergency Use Authorization for Xpertï¾® Xpress CoV-2 plus
On May 12, 2022, Cepheid announced it had received Emergency Use Authorization from the U.S. Food & Drug…
NIH launched clinical trial of Epstein-Barr virus vaccine
On May 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had launched…
Agriculture | CDC | Influenza | Life Science News | USDA
Highly pathogenic Avian influenza detected in a non-commercial backyard flock in Oregon
On May 6, 2022, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) confirmed the…
WHO reported Ebola virus disease in Democratic Republic of the Congo
On Apr. 28, 2022, the Ministry of Health of the Democratic Republic of the Congo declared an outbreak…
U.S. case of Human avian influenza A(H5) virus reported
On Apr. 28, 2022, Centers for Disease Control and Prevention (CDC) reported that a person had tested positive…
USDA took action to ensure continued rapid response to highly hathogenic Avian influenza in the U.S.
On Apr. 27, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service (APHIS) announced that…
USDA issued a conditional license for mink Coronavirus
On Apr. 27, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service announced it had…
Codiak announced new preclinical data supporting development of broadly protective pan beta-Coronavirus vaccine
On Apr. 20, 2022, Codiak BioSciences announced new preclinical data from its pan beta-coronavirus vaccine program, which aims…
Pfizer and BioNTech data demonstrated high immune response following booster dose of COVID-19 vaccine in children 5 through 11 years of age
On Mar. 14, 2022, Pfizer and BioNTech announced positive results from a Phase 2/3 clinical trial evaluating the…
Novavax and Serum Institute of India received EUA for COVID-19 vaccine in Thailand
On Apr. 8, 2022, Novavax announced and Serum Institute of India Pvt. Ltd. (SII), the world’s largest vaccine…
Merck and Ridgeback reported data demonstrating treatment with LAGEVRIO (molnupiravir) associated with more rapid elimination of SARS-CoV-2 than placebo
On Apr. 1, 2022, Merck and Ridgeback Biotherapeutics announced that data evaluating LAGEVRIO(molnupiravir), an investigational oral antiviral COVID-19…
US Food and Drug Administration revised EUA for sotrovimab due to Omicron BA.2 subvariant
On Mar. 25, 2022, GlaxoSmithKline and Vir Biotechnology announced that the US Food and Drug Administration had amended…
Icosavax announced topline interim results from its ongoing Phase 1/2 clinical trial of IVX-411, a VLP vaccine candidate displaying the SARS-CoV-2 receptor-binding domain (RBD).
On Mar. 25, 2022, Icosavax announced the first subjects had been dosed with IVX-411, a virus-like particle (VLP)…
Quest Diagnostics granted CDC contract to support COVID-19 infection and vaccination seroprevalence research
On Mar. 23, 2022, Quest Diagnostics announced that it had been granted a contract by the Centers for…
More than 80 million doses administered to southern African children targeted in mass polio vaccination drives
On Mar. 18, 2022, the World Health Organization (WHO) announced that Malawi had launched the first round of…
Sorrento announced COVISHIELD antibody nasal drops prevent productive SARS-CoV-2 infections
On Mar. 2, 2022, Sorrento Therapeutics announced that new preclinical results demonstrated that pretreating an animal with intranasal…
Medicago and GSK announced approval by Health Canada of COVIFENZ, an adjuvanted plant-based COVID-19 vaccine
On Feb. 24, 2022, Medicago and GlaxoSmithKline announced that Health Canada had granted approval for COVIFENZ, COVID-19 vaccine,…
Health Canada authorized Novavax COVID-19 vaccine
On Feb. 17, 2022, Novavax announced that Health Canada had granted authorization for Nuvaxovidï¾™ COVID-19 Vaccine (Recombinant protein,…
CDC announced H5N1 bird flu virus in U.S. wild birds and poultry posed a low risk to the public
On Feb. 14, 2022, CDC reported that the current risk to the general publicï¾’s health from HPAI A(H5N1)…
Data suggested sotrovimab retained neutralizing activity against Omicron subvariant BA.2
On Feb. 10, 2022, Vir Biotech announced that preclinical data suggested that sotrovimab, an investigational monoclonal antibody authorized…
Research scientists identified vulnerable site on multiple coronaviruses that could be targeted to prevent future pandemics.
On Feb. 10, 2022, Scripps Research announced that the COVID-causing virus SARS-CoV-2 harbors a vulnerable site at the…
NIH-funded study suggested COVID-19 increased risk of pregnancy complications
On Feb. 4, 2022, the NIH announced a study that showed pregnant women with COVID-19 appeared to be…